BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Guermarie Velazquez-Torres, Enrique Fuentes-Mattei, Hyun Ho Choi, Sai-Ching J Yeung, Xiangqi Meng, Mong-Hong Lee. Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growthGastroenterology Report 2020; 8(4): 261 doi: 10.1093/gastro/goaa018
2
Jun Gu, Shiyan Yan, Baochan Wang, Feng Shen, Haixia Cao, Jiangao Fan, Yuqin Wang. Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta-analysis of observational studiesDiabetes/Metabolism Research and Reviews 2016; 32(1): 63 doi: 10.1002/dmrr.2671
3
Erica Dugnani, Gianpaolo Balzano, Valentina Pasquale, Marina Scavini, Francesca Aleotti, Daniela Liberati, Gaetano Di Terlizzi, Alessandra Gandolfi, Giovanna Petrella, Michele Reni, Claudio Doglioni, Emanuele Bosi, Massimo Falconi, Lorenzo Piemonti. Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinomaActa Diabetologica 2016; 53(6): 945 doi: 10.1007/s00592-016-0893-6
4
Zhaoxu Zheng, Rongshou Zheng, Yutong He, Xibin Sun, Ning Wang, Tianhui Chen, Wanqing Chen. Risk Factors for Pancreatic Cancer in China: A Multicenter Case-Control StudyJournal of Epidemiology 2016; 26(2): 64 doi: 10.2188/jea.JE20140148
5
Gianpaolo Balzano, Erica Dugnani, Alessandra Gandolfi, Marina Scavini, Valentina Pasquale, Francesca Aleotti, Daniela Liberati, Gaetano Di Terlizzi, Giovanna Petrella, Michele Reni, Claudio Doglioni, Emanuele Bosi, Massimo Falconi, Lorenzo Piemonti, Surinder K. Batra. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational StudyPLOS ONE 2016; 11(11): e0166008 doi: 10.1371/journal.pone.0166008
6
María Gutiérrez-Salmerón, Ana Chocarro-Calvo, José Manuel García-Martínez, Antonio de la Vieja, Custodia García-Jiménez. Bases epidemiológicas y mecanismos moleculares implicados en las asociaciones de obesidad y diabetes con cáncerEndocrinología, Diabetes y Nutrición 2017; 64(2): 109 doi: 10.1016/j.endinu.2016.10.005
7
María Gutiérrez-Salmerón, Ana Chocarro-Calvo, José Manuel García-Martínez, Antonio de la Vieja, Custodia García-Jiménez. Epidemiological bases and molecular mechanisms linking obesity, diabetes, and cancerEndocrinología, Diabetes y Nutrición (English ed.) 2017; 64(2): 109 doi: 10.1016/j.endien.2016.10.002
8
Trond A Buanes. Pancreatic cancer-improved care achievableWorld Journal of Gastroenterology 2014; 20(30): 10405-10418 doi: 10.3748/wjg.v20.i30.10405
9
Eun Jung Jang, Hyo Kyeong Kim, Hana Jeong, Ye Seul Lee, Mi Gyeong Jeong, Su Jung Bae, Sanghee Kim, Sang Kook Lee, Eun Sook Hwang. Anti-Adipogenic Activity of the Naturally Occurring Phenanthroindolizidine Alkaloid AntofineviaDirect Suppression of PPARγExpressionChemistry & Biodiversity 2014; 11(6): 962 doi: 10.1002/cbdv.201300365
10
Muxing Kang, Wenjie Qin, Miranbieke Buya, Xin Dong, Wen Zheng, Wenjie Lu, Jian Chen, Qingqu Guo, Yulian Wu. VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stressCancer Letters 2016; 373(2): 241 doi: 10.1016/j.canlet.2015.12.031
11
Lucila M. Perrotta de Souza, Jessica P.L. Moreira, Homero S. Fogaça, Ronir R. Luiz, Heitor S. de Souza. Pancreatic Cancer Incidence and Lethality Rates in BrazilPancreas 2017; 46(5): 699 doi: 10.1097/MPA.0000000000000791